These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 3893762)

  • 1. [Treatment of juvenile diabetics with highly purified insulin preparations--effect on the formation insulin antibodies and metabolic compensation].
    Michalková D; Bircák J; Cársky J; Kolár J; Sílesová J; Zmeková-Jancová E
    Cesk Pediatr; 1985 Apr; 40(4):219-23. PubMed ID: 3893762
    [No Abstract]   [Full Text] [Related]  

  • 2. Human insulin and porcine insulin in the treatment of diabetic children: comparison of metabolic control and insulin antibody production.
    Mann NP; Johnston DI; Reeves WG; Murphy MA
    Br Med J (Clin Res Ed); 1983 Nov; 287(6405):1580-2. PubMed ID: 6416511
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation between HbA1c, purified insulins, diabetic control, and insulin antibodies in diabetic children.
    Bistritzer T; Sack J; Theodor R; Weissglass L; Ben-Bassat I; Lahav M
    Horm Res; 1984; 20(3):178-85. PubMed ID: 6386647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative double-blind trial of the effectiveness and antigenicity of semisynthetic human insulin and purified porcine insulin in newly treated diabetic subjects.
    Larkins RG; Zajac J; Saunders R; Read A; Hopper JL
    Aust N Z J Med; 1986 Apr; 16(2):206-10. PubMed ID: 3530226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin antibody response to bovine insulin therapy: functional significance among insulin requiring young diabetics in India.
    Goswami R; Jaleel A; Kochupillai NP
    Diabetes Res Clin Pract; 2000 Jul; 49(1):7-15. PubMed ID: 10808058
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of anti-insulin antibodies on glycemic control in insulin treated diabetic patients.
    Sakata S; Matsuda M; Komaki T; Miura K
    Immunol Invest; 1986 Dec; 15(8):791-9. PubMed ID: 3298026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Glycosylated hemoglobin compared with blood glucose and lipid parameters in diabetics treated with an insulin preparation and diet].
    Preradov-Mikić M
    Med Pregl; 1987; 40(3-4):105-9. PubMed ID: 3312983
    [No Abstract]   [Full Text] [Related]  

  • 8. Normalization of complement activation and consumption in diabetic children and adolescents after switch-over from porcine to semisynthetic human insulin.
    Dorchy H; Duchateau J; D'Hooge D
    Diabete Metab; 1988; 14(4):415-21. PubMed ID: 3066649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Comparison of semisynthetic human insulin and porcine insulin in diabetic patients with or without circulating anti-insulin antibodies].
    Vandeleene B; Ketelslegers JM; Lambert AE
    Acta Clin Belg; 1983; 38(6):360-8. PubMed ID: 6369853
    [No Abstract]   [Full Text] [Related]  

  • 10. [Dynamics of anti-insulin antibodies in diabetes mellitus in children (preliminary note)].
    Alexandru E; Popa I; Deutsch G; Murgu L; Bergel E; Lăzărescu-Pavel D; Schmidt Georoceanu A
    Rev Pediatr Obstet Ginecol Pediatr; 1980; 29(1):79-89. PubMed ID: 6770444
    [No Abstract]   [Full Text] [Related]  

  • 11. [Monocomponent insulins in the treatment of juvenile diabetes].
    Kopecký A; Vavrinec J; Kimlová I; Pospísilová D
    Cesk Pediatr; 1984 Apr; 39(4):223-5. PubMed ID: 6375877
    [No Abstract]   [Full Text] [Related]  

  • 12. [Blood glucose lowering by human insulins and highly purified porcine insulin. Metabolic study in insulin-injecting diabetics].
    Sailer D; Volkholz HJ; Pichl J
    Fortschr Med; 1985 May; 103(19):527-30. PubMed ID: 3891564
    [No Abstract]   [Full Text] [Related]  

  • 13. Do GAD antibodies at IDDM onset predict the clinical course of diabetes in children?
    Kordonouri O; Danne T; Weber B
    Diabetes Care; 1996 Aug; 19(8):901-2. PubMed ID: 8842617
    [No Abstract]   [Full Text] [Related]  

  • 14. [The effect of anti-insulin antibodies and of peptide C residual secretion on the metabolic control of diabetes type 1].
    Velasco N; Díaz de Valdés M; Arteaga A; Acosta AM; Pellegrini MR; Foradori A
    Rev Med Chil; 1990 Jan; 118(1):3-9. PubMed ID: 2152698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Anti-insulin antibodies and their development in relation to therapy].
    Synek M
    Cesk Pediatr; 1987 Oct; 42(10):614-6. PubMed ID: 3322582
    [No Abstract]   [Full Text] [Related]  

  • 16. [New therapeutic approaches and evaluation of metabolic compensation in juvenile diabetes].
    Michalková D; Jancová E; Barák L; Silesová J; Tomecková E
    Cesk Pediatr; 1993 Mar; 48(3):158-63. PubMed ID: 8495521
    [No Abstract]   [Full Text] [Related]  

  • 17. Deleterious effect of anti-insulin antibodies on diabetes control.
    Livneh A; Avraham H; Bistritzer T; Weisglass L; Theodor R; Sack J
    Isr J Med Sci; 1990 Jan; 26(1):11-5. PubMed ID: 2179155
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Children and adolescents with diabetes mellitus. Understanding correlation between glycosylated hemoglobin and diabetes mellitus and its management].
    Knudtzon J; Dahl-Jørgensen K; Meen HD; Baevre H; Søvik O
    Tidsskr Nor Laegeforen; 1983 Feb; 103(5):516-8. PubMed ID: 6346580
    [No Abstract]   [Full Text] [Related]  

  • 19. [Intensive insulin therapy in the diabetic child].
    Bougnères PF
    Union Med Can; 1985 Oct; 114(10):821-8. PubMed ID: 3909569
    [No Abstract]   [Full Text] [Related]  

  • 20. Relationship between insulin antibodies and metabolic control in type I diabetes mellitus.
    Moisés RS; Sá JR; Chacra AR; Russo EM
    Braz J Med Biol Res; 1990; 23(12):1243-52. PubMed ID: 2136556
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.